Lv41
450 积分 2024-09-10 加入
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
7天前
已完结
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
7天前
已完结
Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease
21天前
已完结
Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs. monotherapy
1个月前
已完结
Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs. monotherapy
1个月前
已完结
Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis
2个月前
已完结
Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis
2个月前
已完结
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
2个月前
已完结
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
5个月前
已完结
Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases
5个月前
已完结
皖公网安备34019202002308
